Citi upgraded Anthera Pharma (NASDAQ: ANTH) from Sell to Neutral.

For an analyst ratings summary and ratings history on Anthera Pharma click here. For more ratings news on Anthera Pharma click here.

Shares of Anthera Pharma closed at $4.48 yesterday.